ClinicalTrials.gg
CompletedNCT07012564Updated Jun 10, 2025

Does Vitamin C Improve Postoperative Healing

An interventional study of Vitamin C and Placebo in Impacted Mandibular Third Molar, sponsored by Hacettepe University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-10.

Sponsored by Hacettepe University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Jun 2024, registered May 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

This randomized, split-mouth clinical trial investigates the effect of oral vitamin C supplementation on postoperative recovery following the surgical extraction of impacted mandibular third molars. Fifty-six healthy patients underwent bilateral extractions, with each side randomly assigned to receive either 1000 mg of oral vitamin C or a placebo. The supplementation began one day before surgery and continued through postoperative day 7. The outcome measures included facial swelling assessed through linear measurements (tragus-pogonion, tragus-commissure labiorum, and lateral canthus of the eye-angulus mandible), pain using a visual analog scale (VAS), trismus based on maximum interincisal opening, and early wound healing assessed with the Landry healing index. Analgesic consumption was also recorded. Pain was evaluated using VAS on days 1, 2, and 7. Edema, trismus, and early wound healing were evaluated on postoperative days 2 and 7. The study aims to determine whether vitamin C reduces edema, pain, and trismus, and enhances early soft tissue healing compared to placebo.

Read the detailed description

This randomized, split-mouth clinical trial aimed to investigate the effect of oral vitamin C supplementation on postoperative recovery following the surgical extraction of impacted mandibular third molars. A total of 56 healthy patients requiring bilateral lower third molar extractions were included in the study. Each patient underwent two separate surgeries on both sides, with each side randomly assigned to receive either 1000 mg of oral vitamin C or a placebo.

Vitamin C supplementation started one day prior to surgery and continued for seven days postoperatively. The primary outcomes of the study were facial swelling, pain, trismus, and early soft tissue healing. Facial swelling was assessed using three linear measurements between specific anatomical landmarks: tragus-pogonion, tragus-labial commissure, and lateral canthus of the eye-angulus mandible. Trismus was measured based on maximum interincisal distance. Pain was evaluated using the visual analog scale (VAS) on postoperative days 1, 2, and 7. Edema, trismus, and early wound healing were assessed on postoperative days 2 and 7. Early wound healing was scored using the Landry healing index. Analgesic consumption was also recorded during the postoperative period.

This study was designed to evaluate whether vitamin C supplementation could reduce postoperative edema, pain, and trismus, and improve early soft tissue healing in comparison to placebo in the context of oral surgical procedures. The findings may provide evidence to support the use of vitamin C as an adjunctive therapy in oral surgery.

02

Conditions studied

  • Impacted Mandibular Third Molar

Keywords

  • Vitamin C
  • Wound Healing
  • Third Molar Surgery
  • Oral Surgery
  • Postoperative Recovery
  • Trismus
  • Facial Swelling
  • Pain
  • Analgesic Use
  • Edema
03

In context

Trismus

107 studies on the registry are indexed under Trismus; 19 are open to participants now.

This study's enrollment of 56 is close to the median of 52 across 99 interventional studies indexed under Trismus.

Browse Trismus studies →

Lead sponsor

Hacettepe University is the lead sponsor of 1,007 studies on the registry; 214 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-35 years
  • Systemically healthy
  • Non-smoker
  • No alcohol or substance abuse
  • Bilateral impacted mandibular third molars
  • Mesioangular impaction with a Pederson index of 5-6
  • Voluntary participation
  • Ability and willingness to attend follow-up visits

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or lactation
  • Presence of infection or pain related to third molars
  • Associated pathological conditions (e.g., cysts or tumors)
  • History of previous mandibular third molar extraction
  • Congenital absence of third molars
  • Known allergy to any drug or substance used in the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    Vitamin C

    Patients received 1000 mg of oral vitamin C daily starting one day before surgery through postoperative day 7.

    Dietary Supplement: Vitamin C

  • Placebo comparator
    Placebo

    Patients received an identical-looking placebo tablet once daily for the same duration.

    Other: Placebo

Interventions

  • Dietary supplementVitamin C

    1000 mg oral vitamin C tablet taken daily from one day before surgery to postoperative day 7.

  • OtherPlacebo

    Identical-appearing oral tablet taken on the same schedule as the vitamin C group.

06

What researchers measure

Primary outcomes

  1. Postoperative Facial Swelling

    Facial swelling was measured using three linear distances: tragus-pogonion, tragus-labial commissure, and lateral canthus-mandibular angle.

    Time frame: Postoperative Day 2 and Day 7

  2. Postoperative Pain Score (VAS)

    Pain intensity was assessed using a 10-cm visual analog scale (VAS), with 0 = no pain and 10 = worst possible pain.

    Time frame: Postoperative Days 1, 2, and 7

Secondary outcomes

  1. Trismus (Maximum Interincisal Opening)

    Trismus was assessed by measuring the maximum interincisal distance in millimeters using a caliper.

    Time frame: Postoperative Days 2 and 7

  2. Early Wound Healing (Landry Healing Index)

    Soft tissue healing was evaluated using the Landry healing index, which scores wound healing on a 5-point scale based on tissue color, bleeding, and granulation.

    Time frame: Postoperative Days 2 and 7

  3. Analgesic Consumption

    : The number of analgesic tablets consumed was recorded for each participant.

    Time frame: Postoperative Days 1,2 and 7

07

Study locations

1 site
  • Hacettepe University Faculty of Dentistry
    Ankara, 06100, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07012564
Responsible party
Alper AKTAŞ (Professor, Hacettepe University) — Principal investigator
First posted
Jun 10, 2025
Start date
Jun 1, 2024
Primary completion
Feb 15, 2025
Completion
Mar 1, 2025
Last update
Jun 10, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Ascorbic Acid

Start the discussion